SCHEMBL2115025

SCHEMBL2115025

OC1CCN(C2CCCC(Cl)CC2)CC1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 6/20 0.36
ALPL P05186 1/20 0.34
ALPI P09923 1/20 0.34
ALPG P10696 1/20 0.34
KMT2A Q03164 1/20 0.34
POLB P06746 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PDE7A Q13946 1/20 0.32
OPRM1 P35372 1/20 0.32
OPRD1 P41143 1/20 0.32
OPRK1 P41145 1/20 0.32
OGFRL1 Q5TC84 1/20 0.32
PHGDH O43175 1/20 0.32
MGLL Q99685 1/20 0.32
L3MBTL3 Q96JM7 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2118739 0.96 POLB (0.36) HRH3POLBHSD17B10PDE7AOPRM1
SCHEMBL2118576 0.96 HRH3 (0.38) HRH3ALPLALPIALPGKMT2A
SCHEMBL2116423 0.92 GPR119 (0.34) HRH3POLBKDM4EALDH1A1
SCHEMBL429615 0.85 TSHR (0.40) HRH3KMT2APOLBHSD17B10OPRM1
SCHEMBL2115416 0.84 HRH3 (0.34) HRH3
SCHEMBL2114280 0.83 TSHR (0.41) HRH3KMT2APOLBHSD17B10OPRM1
SCHEMBL2115222 0.83 TSHR (0.45) HRH3KMT2APOLBHSD17B10OPRM1
SCHEMBL2115024 0.82 ALPL (0.35) HRH3ALPLALPIALPGKMT2A
SCHEMBL987309 0.80 TSHR (0.47) HRH3KMT2APOLBHSD17B10OPRM1
SCHEMBL2114621 0.80 TSHR (0.35) HRH3KMT2APOLBHSD17B10OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158652-B2 1-Difluoromethyl-5-{4-[3-(1-piperidinyl)propoxy]phenyl}-2(1H)-pyridone; compounds act as histamine-H3 receptor antagonistic substances or inverse-agonistic substances; useful as preventives or remedies for various circular system diseases, nervous system diseases, metabolic system diseases MSD K.K. (JP) 2012-04-17 US disclosed
US-20080269287-A1 Substituted Pyridone Derivative MSD K.K. (JP) 2008-10-30 US disclosed
EP-1820797-A1 SUBSTITUTED PYRIDONE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269287-A1 Substituted Pyridone Derivative HRH3, HRH4, HRH1 HRH3 1/4885ALPL 4743/4885ALPI 3085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.